GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Staidson (Beijing) Biopharmaceuticals Co Ltd (SZSE:300204) » Definitions » Cyclically Adjusted PB Ratio

Staidson (Beijing) Biopharmaceuticals Co (SZSE:300204) Cyclically Adjusted PB Ratio : 8.62 (As of Jun. 05, 2025)


View and export this data going back to 2011. Start your Free Trial

What is Staidson (Beijing) Biopharmaceuticals Co Cyclically Adjusted PB Ratio?

As of today (2025-06-05), Staidson (Beijing) Biopharmaceuticals Co's current share price is ¥31.04. Staidson (Beijing) Biopharmaceuticals Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ¥3.60. Staidson (Beijing) Biopharmaceuticals Co's Cyclically Adjusted PB Ratio for today is 8.62.

The historical rank and industry rank for Staidson (Beijing) Biopharmaceuticals Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

SZSE:300204' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.5   Med: 3.03   Max: 7.36
Current: 7.36

During the past years, Staidson (Beijing) Biopharmaceuticals Co's highest Cyclically Adjusted PB Ratio was 7.36. The lowest was 1.50. And the median was 3.03.

SZSE:300204's Cyclically Adjusted PB Ratio is ranked worse than
85.91% of 674 companies
in the Biotechnology industry
Industry Median: 1.475 vs SZSE:300204: 7.36

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Staidson (Beijing) Biopharmaceuticals Co's adjusted book value per share data for the three months ended in Mar. 2025 was ¥1.996. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥3.60 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Staidson (Beijing) Biopharmaceuticals Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Staidson (Beijing) Biopharmaceuticals Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Staidson (Beijing) Biopharmaceuticals Co Cyclically Adjusted PB Ratio Chart

Staidson (Beijing) Biopharmaceuticals Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.47 4.60 3.52 2.69 2.04

Staidson (Beijing) Biopharmaceuticals Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.80 1.52 2.12 2.04 1.99

Competitive Comparison of Staidson (Beijing) Biopharmaceuticals Co's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Staidson (Beijing) Biopharmaceuticals Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Staidson (Beijing) Biopharmaceuticals Co's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Staidson (Beijing) Biopharmaceuticals Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Staidson (Beijing) Biopharmaceuticals Co's Cyclically Adjusted PB Ratio falls into.


;
;

Staidson (Beijing) Biopharmaceuticals Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Staidson (Beijing) Biopharmaceuticals Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=31.04/3.60
=8.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Staidson (Beijing) Biopharmaceuticals Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Staidson (Beijing) Biopharmaceuticals Co's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=1.996/115.1156*115.1156
=1.996

Current CPI (Mar. 2025) = 115.1156.

Staidson (Beijing) Biopharmaceuticals Co Quarterly Data

Book Value per Share CPI Adj_Book
201506 3.298 99.500 3.816
201509 3.411 100.500 3.907
201512 3.506 100.600 4.012
201603 3.611 102.200 4.067
201606 3.616 101.400 4.105
201609 3.799 102.400 4.271
201612 3.975 102.600 4.460
201703 4.124 103.200 4.600
201706 4.097 103.100 4.574
201709 4.140 104.100 4.578
201712 4.624 104.500 5.094
201803 4.460 105.300 4.876
201806 4.931 104.900 5.411
201809 5.086 106.600 5.492
201812 5.156 106.500 5.573
201903 5.134 107.700 5.487
201906 3.425 107.700 3.661
201909 3.424 109.800 3.590
201912 3.435 111.200 3.556
202003 3.377 112.300 3.462
202006 3.341 110.400 3.484
202009 3.269 111.700 3.369
202012 3.335 111.500 3.443
202103 3.240 112.662 3.311
202106 3.134 111.769 3.228
202109 3.036 112.215 3.114
202112 3.258 113.108 3.316
202203 3.104 114.335 3.125
202206 2.969 114.558 2.983
202209 2.909 115.339 2.903
202212 2.848 115.116 2.848
202303 2.683 115.116 2.683
202306 2.573 114.558 2.586
202309 2.466 115.339 2.461
202312 2.136 114.781 2.142
202403 2.154 115.227 2.152
202406 2.195 114.781 2.201
202409 2.162 115.785 2.150
202412 1.945 114.893 1.949
202503 1.996 115.116 1.996

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Staidson (Beijing) Biopharmaceuticals Co  (SZSE:300204) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Staidson (Beijing) Biopharmaceuticals Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Staidson (Beijing) Biopharmaceuticals Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Staidson (Beijing) Biopharmaceuticals Co Business Description

Traded in Other Exchanges
N/A
Address
Rongjing Dong Street, No 5 Beijing Economic and Technological Development Zone, Beijing, CHN, 100176
Staidson (Beijing) Biopharmaceuticals Co Ltd is a pharmaceutical company mainly engaged in the research, development, production, and sale of biological products in China. Its products include mouse nerve growth factor injection, intravenous compound polyethylene glycol electrolyte powder solution, gliclazide, nabumetone, and aspirin.
Executives
Zhang Hong Shan Supervisors
Zheng Hong Supervisors
Cheng Jiang Hong Executives
Feng Yu Jing Executives
Ma Li Na Secretary, Director
Zhou Zhi Wen Director
Wang Huan Securities Affairs Representative
Zhang Rong Qin Executives
Xu Jiang Ping Executives
Cao Hai Yan Supervisors
Sun Yan Fang Executives
Jiang Li Xin Director
Gu Jian Ping Director
Xu Xiang Qing Supervisors
Gu Zhen Qi Director

Staidson (Beijing) Biopharmaceuticals Co Headlines

No Headlines